Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
362
-
Total 13F shares, excl. options
-
35.4M
-
Shares change
-
+285K
-
Total reported value, excl. options
-
$7.38B
-
Value change
-
+$61.9M
-
Put/Call ratio
-
9.33
-
Number of buys
-
167
-
Number of sells
-
-168
-
Price
-
$208.49
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2019
403 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2019.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 362 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.4M shares
of 152M outstanding shares and own 23.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.81M shares), VANGUARD GROUP INC (3.51M shares), BROWN CAPITAL MANAGEMENT LLC (1.64M shares), BAMCO INC /NY/ (1.57M shares), WELLINGTON MANAGEMENT GROUP LLP (1.54M shares), JANUS HENDERSON GROUP PLC (1.38M shares), Neuberger Berman Group LLC (1.36M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.35M shares), Mairs & Power INC (1.07M shares), and Invesco Ltd. (1.06M shares).
This table shows the top 362 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.